Influence of symbiotic administration on gut microbiota: an exploratory study at different levels and intensity of spinal cord injury

Elisa García-Vences , Estefania De la Cruz Castillo , Roxana Rodriguez-Barrera , Adrian Flores Romero , Teresa Ponce-López , David R. Mayen-Quinto , Hector Faustino Noyola-Villalobos , Ivan Ignacio Mejía , Marco Antonio Vargas-Hernández , Exsal Manuel Albores-Méndez , Andrea P. Ibarra-García , Antonio Ibarra

Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004160

PDF (3152KB)
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) :1004160 DOI: 10.37349/ent.2026.1004160
Original Article
research-article
Influence of symbiotic administration on gut microbiota: an exploratory study at different levels and intensity of spinal cord injury
Author information +
History +
PDF (3152KB)

Abstract

Aim: Spinal cord injury (SCI) disrupts autonomic regulation of the gastrointestinal tract, resulting in altered motility, microbial dysbiosis, and decreased production of short-chain fatty acids such as butyrate, a metabolite with neuroprotective properties. This study aimed to evaluate the effects of SCI level and severity on gut microbiota composition and butyrate concentration, and to determine the impact of symbiotic supplementation with Enterococcus faecium and agave inulin on microbial and metabolic recovery. Methods: Twenty female Sprague Dawley rats were randomized into five groups: Sham, thoracic five moderate (T5M), thoracic five severe (T5S), thoracic nine moderate (T9M), and thoracic nine severe (T9S). Fecal samples were collected four weeks post-injury and again after four weeks of daily symbiotic administration. Butyrate levels were quantified by gas chromatography, and microbial composition was analyzed by 16S ribosomal RNA (16S rRNA) sequencing (V3–V4 region). Locomotor recovery was assessed weekly using the Basso, Beattie, and Bresnahan (BBB) scale. Results: All SCI groups displayed significant dysbiosis compared with Sham, characterized by decreased relative abundance of butyrate-producing genera such as Clostridium at week four, as confirmed in the main dataset. Following symbiotic supplementation, Bifidobacterium, Lactobacillus, and Clostridium levels showed partial restoration, although responses varied by injury site and severity. The T9M group demonstrated the most consistent recovery of butyrate-producing taxa; however, butyrate concentration decreased after treatment, while T9S showed a significant increase in butyrate concentration, and T5S exhibited minimal change. Motor recovery was greatest in T9M, followed by T9S and T5M, with no significant improvement in T5S. Conclusions: SCI level and severity strongly influenced microbial dysbiosis, butyrate metabolism, and motor recovery. Symbiotic supplementation partially restored butyrate-producing bacterial taxa, with the most pronounced metabolic and functional benefits observed in the T9M group. These findings support a level-dependent role of gut-brain axis modulation as a potential therapeutic strategy after SCI.

Keywords

spinal cord injury / gut microbiota / symbiotic administration

Cite this article

Download citation ▾
Elisa García-Vences, Estefania De la Cruz Castillo, Roxana Rodriguez-Barrera, Adrian Flores Romero, Teresa Ponce-López, David R. Mayen-Quinto, Hector Faustino Noyola-Villalobos, Ivan Ignacio Mejía, Marco Antonio Vargas-Hernández, Exsal Manuel Albores-Méndez, Andrea P. Ibarra-García, Antonio Ibarra. Influence of symbiotic administration on gut microbiota: an exploratory study at different levels and intensity of spinal cord injury. Exploration of Neuroprotective Therapy, 2026, 6 (1) : 1004160 DOI:10.37349/ent.2026.1004160

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology. 2016; 5: e73.

[2]

Robles Alonso V, Guarner F. Linking the gut microbiota to human health. Br J Nutr. 2013; 109: S21-6.

[3]

Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil. 2013; 25: 713-9.

[4]

Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014; 13: 69-86.

[5]

Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem Int. 2016; 99: 110-32.

[6]

Forsythe P, Kunze WA. Voices from within: gut microbes and the CNS. Cell Mol Life Sci. 2013; 70: 55-69.

[7]

Kirshblum SC, Waring W, Biering-Sorensen F, Burns SP, Johansen M, Schmidt-Read M, et al. Reference for the 2011 revision of the International Standards for Neurological Classification of Spinal Cord Injury. J Spinal Cord Med. 2011; 34: 547-54.

[8]

Furlan JC, Sakakibara BM, Miller WC, Krassioukov AV. Global incidence and prevalence of traumatic spinal cord injury. Can J Neurol Sci. 2013; 40: 456-64.

[9]

Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 2001; 26: S2-12.

[10]

Braddom R. Physical Medicine and Rehabilitation. Philadelphia: WB Saunders Company; 2000.

[11]

Stone JM, Nino-Murcia M, Wolfe VA, Perkash I. Chronic gastrointestinal problems in spinal cord injury patients: a prospective analysis. Am J Gastroenterol. 1990; 85: 1114-9.

[12]

Glickman S, Kamm MA. Bowel dysfunction in spinal-cord-injury patients. Lancet. 1996; 347: 1651-3.

[13]

Lynch AC, Antony A, Dobbs BR, Frizelle FA. Bowel dysfunction following spinal cord injury. Spinal Cord. 2001; 39: 193-203.

[14]

Levi R, Hultling C, Nash MS, Seiger Å. The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Spinal Cord. 1995; 33: 308-15.

[15]

Gungor B, Adiguzel E, Gursel I, Yilmaz B, Gursel M. Intestinal Microbiota in Patients with Spinal Cord Injury. PLoS One. 2016; 11: e0145878.

[16]

Kigerl KA, Mostacada K, Popovich PG. Gut Microbiota Are Disease-Modifying Factors After Traumatic Spinal Cord Injury. Neurotherapeutics. 2018; 15: 60-7.

[17]

O’Connor G, Jeffrey E, Madorma D, Marcillo A, Abreu MT, Deo SK, et al. Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model. J Neurotrauma. 2018; 35: 2159-66.

[18]

Lanza M, Campolo M, Casili G, Filippone A, Paterniti I, Cuzzocrea S, et al. Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury. Mol Neurobiol. 2019; 56: 3937-47.

[19]

Khalkhali S, Mojgani N. Enterococcus faecium; a Suitable Probiotic Candidate for Modulation of Immune Responses Against Pathogens. Int J Basic Sci Med. 2017; 2: 77-82.

[20]

Wang Y, Wu Y, Wang Y, Xu H, Mei X, Yu D, et al. Antioxidant Properties of Probiotic Bacteria. Nutrients. 2017; 9: 521.

[21]

Holscher HD, Bauer LL, Gourineni V, Pelkman CL, Fahey GC, Swanson KS. Agave Inulin Supplementation Affects the Fecal Microbiota of Healthy Adults Participating in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Nutr. 2015; 145: 2025-32.

[22]

Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017; 14: 491-502.

[23]

Bao T, Wang Z, Zhu L, Lu H, Wang T, Zhang Y, et al. Inulin increases the proportion of monocytic myeloid-derived suppressor cells in peripheral blood, liver, spleen and regulates the secretion of plasma inflammatory cytokines in mice with non-alcoholic fatty liver disease. Chin J Cell Mol Immunol. 2020; 36: 228-35.

[24]

Divyashri G, Krishna G, Muralidhara, Prapulla SG. Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: In vitro and in vivo evidence. J Med Microbiol. 2015; 64.

[25]

Scheff SW, Rabchevsky AG, Fugaccia I, Main JA, Lumpp JE Jr. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma. 2003; 20: 179-93.

[26]

Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995; 12: 1-21.

[27]

Lin R, Xu J, Ma Q, Chen M, Wang L, Wen S, et al. Alterations in the fecal microbiota of patients with spinal cord injury. PLoS One. 2020; 15: e0236470.

[28]

Kigerl KA, Hall JCE, Wang L, Mo X, Yu Z, Popovich PG. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 2016; 213: 2603-20.

[29]

Wang Z, Burwinkel M, Chai W, Lange E, Blohm U, Breithaupt A, et al. Dietary Enterococcus faecium NCIMB 10415 and zinc oxide stimulate immune reactions to trivalent influenza vaccination in pigs but do not affect virological response upon challenge infection. PLoS One. 2014; 9: e87007.

[30]

Reineccius G, Health H. Flavor Chemistry and Technology. 2nd ed. Taylor & Francis; 2006.

[31]

D’hoe K, Conterno L, Fava F, Falony G, Vieira-Silva S, Vermeiren J, et al. Prebiotic Wheat Bran Fractions Induce Specific Microbiota Changes. Front Microbiol. 2018; 9: 31.

PDF (3152KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉